Location History:
- Madrid, ES (2009)
- Juan de la Cierva, ES (2011)
Company Filing History:
Years Active: 2009-2011
Title: Innovations by Mercedes Alonso Giner
Introduction
Mercedes Alonso Giner is a notable inventor based in Juan de la Cierva, Spain. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds with therapeutic applications. With a total of 2 patents, his work focuses on innovative solutions for degenerative diseases.
Latest Patents
One of his latest patents is titled "Isoquinoline derivatives as calpain inhibitors." This invention relates to derivative compounds of partially-reduced isoquinoline, which include a sec-butyl group at position 3, exhibiting calpain inhibitor activity. The inventive compound comprises an ester or amide derived from (3-sec-butyl-1-oxo-2,3-dihydro-1H-isoquinolin-4-yliden)-acetic acid and (3-sec-butyl-1-thioxo-2,3-dihydro-1H-isoquinolin-4-yliden)-acetic acid. These compounds can be utilized in the preventive or therapeutic treatment of degenerative diseases.
Another significant patent is "Biphenyl derived thiamides as calpain inhibitors." This invention involves compounds derived from biphenyl that demonstrate activity as calpain inhibitors. One notable compound is a 2,2'-disubstituted biphenyl, where the substituents in the 2 and 2' positions are chains containing structures related to amino acids. These compounds also have applications in the preventive or therapeutic treatment of degenerative diseases.
Career Highlights
Mercedes Alonso Giner is affiliated with the Consejo Superior de Investigaciones Científicas, a prominent research institution in Spain. His work has been instrumental in advancing the understanding of calpain inhibitors and their potential therapeutic uses.
Collaborations
He has collaborated with notable colleagues, including Bernardo Herradon Garcia and Esperanza Benito Cano, who have contributed to his research endeavors.
Conclusion
Mercedes Alonso Giner's innovative work in the field of medicinal chemistry highlights his commitment to developing new therapeutic solutions. His patents reflect a dedication to addressing significant health challenges through scientific research and innovation.